Skip to content

Independent Advisor Alliance: ADME position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Independent Advisor Alliance on ADME, newest first. How the timeline and the estimate are built.

Independent Advisor Alliance held 28,980 ADME shares at 2026-06-30 per its 13F-HR filed 2026-08-12.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 28,980 shares
    Change vs previous 13F -34,146 shares

    0.04% of the 13F portfolio, value $1,612,629.

    13F-HR 0001062993-26-004213 filed by Independent Advisor Alliance
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 63,126 shares
    Change vs previous 13F +35,712 shares

    0.03% of the 13F portfolio, value $3,120,322.

    13F-HR 0001062993-26-002523 filed by Independent Advisor Alliance
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 27,414 shares
    Change vs previous 13F +17,781 shares

    0.03% of the 13F portfolio, value $1,406,633.

    13F-HR 0001062993-26-000608 filed by Independent Advisor Alliance
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 9,633 shares
    Change vs previous 13F -183 shares

    0.01% of the 13F portfolio, value $491,882.

    13F-HR 0001062993-25-016436 filed by Independent Advisor Alliance
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 9,816 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $473,116.

    13F-HR 0001062993-25-014025 filed by Independent Advisor Alliance
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).